ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	8/23	167/7206	2.56651647434e-08
ko04612	Antigen processing and presentation	6/23	77/7206	1.06768910327e-07
ko04217	Necroptosis	6/23	178/7206	1.48602694632e-05
ko05145	Toxoplasmosis	5/23	126/7206	3.94558964881e-05
ko04640	Hematopoietic cell lineage	4/23	64/7206	4.41488177049e-05
ko05140	Leishmaniasis	4/23	75/7206	8.25117021867e-05
ko05340	Primary immunodeficiency	3/23	30/7206	0.000109033210643
ko05168	Herpes simplex infection	5/23	182/7206	0.000226099399074
ko05152	Tuberculosis	5/23	187/7206	0.000256581635744
ko04659	Th17 cell differentiation	4/23	106/7206	0.000315811728689
ko05321	Inflammatory bowel disease (IBD)	3/23	56/7206	0.000705204931077
ko05310	Asthma	2/23	17/7206	0.00128736419253
ko05332	Graft-versus-host disease	2/23	18/7206	0.00144547611224
ko05330	Allograft rejection	2/23	24/7206	0.00257734721716
ko04658	Th1 and Th2 cell differentiation	3/23	96/7206	0.00334476045543
ko05146	Amoebiasis	3/23	99/7206	0.00364894984874
ko05320	Autoimmune thyroid disease	2/23	29/7206	0.00375474270678
ko04940	Type I diabetes mellitus	2/23	32/7206	0.00456048960186
ko05150	Staphylococcus aureus infection	2/23	36/7206	0.00574786094403
ko04672	Intestinal immune network for IgA production	2/23	37/7206	0.00606455889288
ko05162	Measles	3/23	120/7206	0.00625463898267
ko04514	Cell adhesion molecules (CAMs)	3/23	130/7206	0.00780405860623
ko05160	Hepatitis C	3/23	153/7206	0.012172258265
ko03050	Proteasome	2/23	54/7206	0.0126093149251
ko04621	NOD-like receptor signaling pathway	3/23	157/7206	0.0130501106103
ko05416	Viral myocarditis	2/23	55/7206	0.0130598997665
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/23	191/7206	0.0219749161166
ko05133	Pertussis	2/23	87/7206	0.0309341204107
ko05323	Rheumatoid arthritis	2/23	89/7206	0.0322570360815
ko04620	Toll-like receptor signaling pathway	2/23	100/7206	0.0399227891334